.RESEARCH FEATURE.06 August 2024.
A huge randomized regulated trial with cisgender ladies highlights the obstacles of adherence to a regular oral preexposure prophylaxis program and also demonstrates that twice-yearly shot of lenacapavir can easily keep effective HIV avoidance levels over 6 months.